Associate Professor Ankur Singh is the Chair of Lifespan Oral Health and an Australian Research Council DECRA fellow at the University of Sydney, Australia. Ankur is the Associate Editor of Community Dentistry Oral Epidemiology and is on the Advisory Committee of Journal of Dental Research. Ankur has multiple significant international leadership positions in oral health and public health including President (Elect) of the Global Oral Health Inequalities Research Network of International Association for Dental Research, is the Chair of the Global Working Group of Social Determinants of Health at the International Union for Health Promotion and Education and is the Co-Chair of the International Social Epidemiology Society.

Ankur leads a dynamic and evolving research program within his Chair of Lifespan Oral Health position, which is well recognised nationally and internationally for generating policy relevant evidence using advanced data analytics including simulation modelling and causal inference approaches combined with deep theoretical knowledge of social determinants of health and health inequalities. Ankur has made significant contributions in areas of population oral health, specifically, in improving understanding of social inequalities in oral health outcomes and its solutions. In addition, he has made important contributions in social determinants of health, multimorbidity and tobacco control. Ankur collaborates extensively internationally with colleagues in India, United Kingdom, Brazil, USA, Cambodia, Indonesia and Singapore and is an Adjunct Professor with Universitas Airlangga (Indonesia), is Adjunct Faculty at Public Health Foundation of India and is Honorary Principal Fellow at the Melbourne School of Population and Global Health, University of Melbourne.

​

David Heymann is a medical epidemiologist and Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine. From 2009 to 2017 he was chair of the UK Health Protection Agency and then Public Health England, and during this period he also led the Centre on Global Health Security at Chatham House (London). From 1989 to 2009 Heymann held various leadership positions in infectious diseases at WHO, and in 2003 headed the WHO global response to SARS in his role as executive director of communicable diseases. In 1976, after spending two years working in India on smallpox eradication, Heymann was a member of the CDC (Atlanta) team to investigate the first Ebola outbreak in DRC and stayed on in sub-Saharan Africa for 13 years in various field research positions on Ebola, monkeypox, Lassa Fever, malaria and other tropical diseases. Heymann has published over 275 peer reviewed articles and book chapters, is editor of the Control of Communicable Diseases Manual, and is an elected member of the UK Academy of Medical Sciences and the US National Academy of Medicine. In 2009 he was named an Honorary Commander of the Most Excellent Order of the British Empire for services to global health.

Dr. Giridhara R. Babu (Giri) obtained his MBBS degree from Kasturba Medical College, Manipal, as well as his MPH and PhD in Epidemiology from UCLA, where he trained under Professor Roger Detels. He is a Fellow of the Faculty of Public Health in the United Kingdom and a chartered member (CPH, first batch) of the US National Board of Public Health Examiners. Furthermore, he is a former Wellcome Trust-DBT Intermediate and Senior Fellow. Giri works as Professor of Population Medicine at the College of Medicine, QU Health, Qatar University. Earlier, he worked as Professor and Head of Life-Course Epidemiology at the Public Health Foundation of India. He is an internationally recognized epidemiologist whose work aims to reduce the burden of infectious diseases and to address the developmental and environmental origins of the infectious and non-communicable disease burden in low- and middle-income countries.

Giri has over twenty years of experience in South Asia and the Middle East, focusing on infectious disease epidemiology. He began as a field epidemiologist with the WHO Polio Surveillance Project in India, overseeing surveillance during a key phase of the Global Polio Eradication Initiative. This enhanced his understanding of disease transmission, outbreak management, and infrastructural vulnerabilities in high-burden areas. His research has focused on tuberculosis, vector-borne diseases, and enteric infections, highlighting how socioeconomic factors, overcrowding, and environmental exposures elevate risks for urban populations in low- and middle-income countries. He worked on disease reprioritization for surveillance in India. During the COVID-19 pandemic, Dr. Babu served on the ICMR National Task Force and the Lancet COVID-19 Commission India, shaping urban containment strategies. He advised state governments, collaborated with the WHO South-East Asia Region on COVID-19 risk assessment tools, and helped finalize a regional meningitis framework. His media and print communications are vital in educating the public about health.

Ranked among the top 2% of scientists worldwide by Scopus-Clarivate, Gir has authored over 200 peer-reviewed publications. He holds Visiting Professorships at Maastricht University (CAPHRI, Netherlands) and serves as an Academic Editor at PLOS Global Public Health. Dr. Babu has supervised 13 doctoral students across Qatar, India, Belgium, and the Netherlands.

Links: X: https://x.com/grbepi ; TEDx: https://www.youtube.com/watch?v=2onLKM4-zUY

Web: https://giridhar.org/

Dr. Habib Hasan Farooqui is a faculty member at the College of Medicine, Qatar University. He previously served as Additional Professor of Health Economics at the Public Health Foundation of India (2008–2025), Post-Doctoral Fellow at the London School of Hygiene and Tropical Medicine (2013–2014), and Surveillance Medical Officer at the World Health Organization (2007–2008).

He holds a Doctor of Medicine degree from the Institute of Medical Sciences, Banaras Hindu University (2007), and a PhD from Maastricht University (2025). He has received formal training in Econometrics from the London School of Economics, Mathematical Modelling of Infectious Diseases from Imperial College London, and Pedagogy from Boston University.

Dr. Farooqui has served as a technical expert on several prestigious international advisory bodies, including the WHO Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC), the WHO Advisory Group on the Research and Development of Antibacterial Treatments, the Royal Institute of International Affairs (Chatham House, UK), and the Board of Immunization Economics (USA). He has also provided technical advice to WHO-SEARO, WHO India, WHO Maldives, the Ministry of Health and Family Welfare (India and Maldives), and the Competition Commission of India.

His research and teaching focus on infectious disease epidemiology and the economics of vaccine-preventable diseases. He has generated the first state-specific estimates of pneumonia-related mortality and morbidity in India, which informed the introduction of the Pneumococcal Conjugate Vaccine (PCV). He has also reported the first national estimates on antibiotic prescription and consumption in India and evaluated the impact of key health policies, including Mission Indradhanush, Schedule H1, and Drug Price Control Orders.

Dr. Farooqui has supervised over 30 master’s-level students, published more than 100 peer-reviewed articles and book chapters, and served as an editor and reviewer for leading international journals.

Associate Professor Itismita Mohanty is a nationally recognised health economist with over 15 years of experience in research and academia in Australia and India. Based at the Health Research Institute, University of Canberra, she specialises in health economic evaluation, advanced statistical and econometric modelling of health data, and applied health services research. Her work drives evidence-based health system decision-making through sophisticated health data modelling—encompassing patient care pathways, behavioural dynamics, disease-specific forecasting, and service utilisation. She applies advanced health economic evaluation techniques, including Cost-Effectiveness, Cost–Utility, and Social Return on Investment analyses, to generate actionable insights that shape policy, funding, and program design across diverse healthcare settings.
Dr Mohanty has led and contributed to major funded projects aimed at improving population health outcomes and system efficiency. Her research has supported key Australian government stakeholders, including the Commonwealth Department of Health, Geoscience Australia, ACT Primary Health Network, and the Australian Institute of Health and Welfare. She has served on expert panels for Health Economics and Health Data Analytics for Commonwealth Department of Health and assessed grants for the Medical Research Future Fund in Australia and the Health Research Council of New Zealand.
Her portfolio spans chronic disease management, integrated primary care, preventive health, and disaster resilience modelling. Internationally, she has led multi-country studies on maternal and child health, social determinants of health, and equity-informed evaluations across South and Southeast Asia. With nearly 50 peer-reviewed publications and over 10 public policy reports, her work is widely cited and has shaped national and global health policies.
Dr Mohanty’s translational research has delivered high-impact evaluations of mental health programs for veterans and first responders, cost-effective disaster resilience systems, and ACT Health-funded initiatives in brain cancer and cardiac rehabilitation. Over the past five years, she has secured more than $8 million in competitive funding, successfully guided six PhD students to completion, and currently mentors six more.

​

Justice Nonvignon is Technical Director of Health Economics and Financing at Management Sciences for Health. He is also Professor of Health Economics at University of Ghana School of Public Health. Previously, he served as foundation Head of the Health Economics and Financing Division at the Africa Centres for Disease Control and Prevention, an autonomous technical health agency of the African Union based in Addis Ababa, Ethiopia. He is a public health researcher with extensive experience in teaching and mentoring students and engaging with policymakers from various countries in Africa.

Nonvignon has a long history of leveraging health technology assessments and health economics evidence to strengthen public health programs, including in dozens of countries in Africa. He served for many years as Chair of the Technical Working Group at the Ghana Ministry of Health’s HTA Secretariat where he oversaw many important tasks. At Africa CDC, he led the development of the continent’s first framework for evidence-informed priority setting that produced guidance on institutionalizing EIPS, HTA on the continent. He has also contributed to supporting HTA work in many African countries and frequently speaks on global platforms on global health and health financing transitions.

He frequently advises major global health players including WHO, UNICEF, the World Bank, USAID, and others. He has served on over 30 at the national and global levels, including member of the Technical Advisory Panel of the Pandemic Fund hosted by the World Bank, Strategic and Technical Advisory Group on infectious hazards of epidemic and Pandemic potential, the Gavi Evaluation Advisory Committee, Co-Chair of the Ministry of Health Ghana's Health Technology Assessment Technical Working Group, and member of the advisory board of the Global Health Economic Centre at the London School of Hygiene and Tropical Medicine. He is a past Chair of the Global Evaluation and Monitoring Network for Health, a network of 11 universities in 9 countries across Africa, Asia, Latin America and the United States of America leading monitoring and evaluation capacity strengthening and technical assistance. He is also an Adjunct Professor of Global Health at Duke University, USA, Honorary Research Professor at Strathclyde University, UK, Adjunct Faculty at Public Health Foundation of India, and previously Adjunct Faculty at New York University’s College of Global Public Health. Justice has published over 120 peer review articles, and commentaries in the areas of health economics, financing, policy, monitoring and evaluation.
​

Joel Negin is Professor of Global Health at the University of Sydney. He was Acting Deputy Executive Dean in the Faculty of Medicine and Health April 2023-August 2024 and was Head of the School of Public Health from November 2015 to April 2023.Currently, he is leading a University-wide project on Academic Excellence in the Office of the Provost.

After graduating from Harvard and Columbia Universities, Joel then worked for a number of years in sub-Saharan Africa on health and development projects before moving to Australia. In those years, he lived and worked in South Africa, Zimbabwe, Botswana and Kenya and collaborated with governments, the World Bank, academic institutions and United Nations partners.

Joel started at the School of Public Health in 2008 as a lecturer in the Masters of International Public Health program and has always loved teaching and the interaction with students. He is passionate about international collaboration and developing reciprocal partnerships. Joel currently conducts research at the intersection of ecology and infectious diseases in Southeast Asia and the Pacific.

Dr. Jacob Eapen is a global paediatrician and a renowned public health physician. After completing his MBBS from Trivandrum Medical College Dr.Eapen continued his post-graduation both at Christian Medical College Vellore and CMC Ludhiana. Then he was a consultant paediatrician with Aga Khan Foundation hospital in Dar-Es-Salaam, Tanzania and then took up an assignment with University teaching hospital in Nigeria for 3 years. In 1984 he proceeded to USA for further studies and attended the University of California, Berkeley for his Masters in Public Health. Then he took an assignment with the United Nations High Commissioner of Refugees (UNHCR) where he was responsible for the lives of about 60,000 indo-Chinese refugees. After his return he completed his MD from University of Stanford at Palo Alto. Currently he serves as the medical director of Alameda Health System (retired) one of the largest public health systems in California. He is a well-recognised international public health consultant and has given several media presentations and guest lecture around the world. He has served in several State health care boards in California on a State level and also a recipient of several awards.
• Recipient of the prestigious Eilis Island Medal of Honour. 6 American presidents are also previous recipients.
• Recipient of the first California Medical Board’s physician recognition award. The largest medical board in the country.
• Global President- Pravasi World Malayalee Council-PWMC
​

Kaja Abbas is an Associate Professor at the London School of Hygiene & Tropical Medicine and Nagasaki University. His research area is vaccine impact modelling with a focus on estimating the health, economic, and equity impact of vaccination programmes to support evidence-based decision-making on vaccination strategies in collaboration with partners and stakeholders at the global, regional, and national levels. He has worked on the impact assessment of existing and new vaccines to inform vaccine policy and programmatic decision-making in varied contextual settings.

He serves on various expert advisory committees on vaccines, including the UK JCVI (Joint Committee on Vaccination and Immunisation), the WHO SAGE (Strategic Advisory Group of Experts on Immunization) working group on chikungunya vaccines, and the WHO TAG (Technical Advisory Group) on vaccines against Klebsiella pneumoniae. He holds honorary appointments at the Public Health Foundation of India and the National Institute of Infectious Diseases, Japan Institute for Health Security.

He holds a B.Tech (Bachelor of Technology) in Metallurgical and Materials Engineering from the Indian Institute of Technology Kharagpur, an MS (Master of Science) and a PhD in Computer Science from the University of North Texas, and an MPH (Master of Public Health) from the University of Rochester.

​

Michael Walsh is a landscape epidemiologist and disease ecologist with the Sydney School of Public Health and the Sydney Infectious Diseases Institute (Sydney ID). He is interested in the complex ecologies of zoonotic pathogens and their interaction with hosts, vectors, and environments to shape risk. As such, he combines methods from spatial and infectious disease epidemiology with applications of biogeography, community ecology, and landscape ecology to employ transdisciplinary One Health approaches to zoonosis inference, prediction, surveillance, and prevention. Michael is particularly interested in the ways in which interactions between wildlife, domesticated animals, and humans in disturbed landscapes facilitate pathogen spillover from primary reservoir hosts to novel hosts. Michael has 26 years' experience as an epidemiologist and is currently investigating zoonotic arbovirus spillover at the wildlife-livestock-human in India and Australia. Michael has taught infectious disease epidemiology and epidemiological methods for 22 years on the faculties of New York University, the State University of New York, Downstate, and, currently, at the University of Sydney.​

Professor Grills (DPHIL, DPH, MBBS, MPH) is a Public Health Physician, Senior Research Fellow at the Aii and India Director for the Faculty of Medicine (University of Melbourne). For 20 years he has researched public health and disability in India. He collaborates with the Indian Ministry of Social Justice and Empowerment on disability and leads VirtuCare which designs disability inclusive digital health platforms in India. He has extensively researched the NGOs response to HIV and disability India.​

Professor Ollie Jay is Professor of Heat and Health and Academic Director of the Heat and Health Research Centre at The University of Sydney. He is a NHMRC Investigator Grant recipient for his research program entitled "Heat and Health: Building resilience to a warming planet across the human lifespan".
Prof Jay has led several large-scale projects that have directly influenced international public health heatwave policies in the United States, Europe, and Australia. He recently partnered with Google to deliver his team's research on evidence-based personal cooling strategies through heat warning alerts worldwide. He has also led extreme heat policy development for Sports Medicine Australia, Tennis Australia (Australian Open), and Cricket Australia, and was the Lead Heat Consultant for the Australian Olympic Team in the Paris 2024 games. Prof Jay is also a co-Founder of EMU Systems—a spin-out venture delivering heat stress monitoring and management systems for sport and industry.
Prof Jay has published >230 peer-reviewed articles, including senior author papers in JAMA, NEJM, Lancet, Nature, Annals of Internal Medicine, and Lancet Planetary Health. He has been profiled by The Lancet, and his research program has been featured in Science and Nature highlighting its lead global contribution to protecting society’s most vulnerable to the heat. Since 2024, Ollie has served as Chair of the “Hazards and Impacts” Working Group for the Global Lancet Countdown on Health and Climate Change team.
He has received funding from organisations such as the National Health and Medical Research Council (NHMRC), Wellcome Trust (UK), Minderoo Foundation, the NSW Department of Planning, Industry and Environment, and Multiple Sclerosis Research Australia.
​

With over 27 years of experience in medical education, community medicine, and health systems development. He currently serves as professor and chief of the School of Public Health and Community Medicine at BP Koirala Institute of Health Sciences (BPKIHS), Nepal, one of the country’s leading institutions, known for its extensive outreach across primary health care centres, district hospitals, and zonal hospitals in eastern Nepal.
Dr. Pokharel holds dual MD degrees in general medicine and community medicine. He has played a pivotal role in shaping public health education and practice in South Asia. As the founding architect of the School of Public Health at BPKIHS, he also established the Department of Occupational Health within the school. He is a strong advocate for universal access to basic occupational health services for workers across all sectors in Nepal.
Beyond academia, his leadership extends into national and regional health policy. As vice-chair of GARP Nepal, he actively promotes antimicrobial resistance (AMR) stewardship, working closely with both provincial and federal health ministries. He also chairs the Oxford Clinical Research Unit Nepal—a nonprofit organization supported by the Welcome Trust—and serves on the academic committee of the Indian Institute of Public Health under the Public Health Foundation of India, New Delhi.
Dr. Pokharel is a member of the senate, the highest governing council of BPKIHS, and has contributed to several academic, curriculum, and infection control committees. His commitment to regional collaboration is reflected in his role as regional technical advisor to the WHO South-East Asia Advisory Committee on Health Research (SEA-ACHR).
Earlier in his career, he contributed to the foundational phase of the Kathmandu University School of Medical Sciences, where he served as chair of the Department of Community Medicine and Family Practice. He is actively involved in academic publishing and serves on the editorial boards or as an associate editor for several national and international health science journals. His affiliations include the Journal of Migration and Health, BMJ Public Health and others.
​

Dr Kalliecharan is a Health Planner/Policy Analyst with specialised knowledge and expertise in Health Policy, Planning and Management; Health Sector Financing; Health Systems Research; and Education Capacity Development (focusing on Health Systems Strengthening). He lecturers at the Nuffield Centre - School of Medicine on the Master of Public Health, MSc International Health and is the joint programme lead for the online MSc- Global Health.

His work within the health and other sectors include:
• Service provision and programme management at the district level;
• Policy development and health planning at the regional and national levels;
• Lecturing and research with academic institutions and;
• Consulting for Health Authorities and International Organisations.

He has over thirty-five years of experience in health management and health systems development through his work in Canada, the Caribbean, the UK and a number of short-term consultancies in countries including, China, Iran, Tanzania, Sudan, Turkey, India, Grenada, Netherlands, Germany, Kazakhstan and Bangladesh.

Ricky’s research and academic interests lie in the areas of health policy, planning and management; health sector financing and capacity strengthening of training institutions in public health management and health systems development. He has led quality assurance process through his roles as the Sub-Dean for Post Graduate Assessment and the Director of Student Education in the School of Medicine, University of Leeds.
​

Professor Shaban is a leading internationally credentialed practising clinical expert infection control practitioner with particular strengths in high-consequence infectious diseases, disease control, emergency care and health protection. As Clinical Chair, he is Chief Infection Control Practitioner and District Director of Communicable Disease Control and Infection Prevention for Western Sydney Local Health District, providing strategic and operational leadership of infection prevention and disease control services. He is also an Associate Director of the New South Wales Biocontainment Centre, Australia's first purpose-built state-of-the-art facility for the prevention, containment and management of high-consequence infectious disease located at Westmead Hospital in New South Wales. He and a team of his colleagues identified and managed the first cases of COVID-19 in NSW at Westmead Hospital, and MPox within New South Wales, and he provides ongoing leadership for the state and national response to infectious diseases of consequence.​

Dr. Sanjay Kinra is a Professor of Clinical Epidemiology at the London School of Hygiene & Tropical Medicine and Honorary Consultant at the UK Government’s Department of Health and Social Care. His research interests are in understanding the causes of, and developing affordable solutions for, the management of chronic conditions and ageing in India. He co-directs a longstanding cohort study in rural Telangana (APCAPs; https://apcaps.lshtm.ac.uk), which is monitoring the health and lifestyles of 10,000 individuals through state-of-the-art clinical, molecular and digital technologies, to study the risk factors and develop affordable molecular and digital diagnostics for conditions such as heart disease, diabetes, dementia and ageing. He have conducted several clinical trials of culturally tailored interventions for self-management of chronic conditions by leveraging advances in behavioural science, enabling less skilled workers with digital technology, and use of traditional therapies such as yoga and Ayurveda. Nowadays, He is mainly interested in the studying the potential of applications of Artificial intelligence and Generative Language Models to health challenges in underserved settings.

Positions Held

• Chair of British Medical Association (BMA)conference Committee 2022/3
• Member Public Health Medicines Consultants Committee (PHMCC) of BMA
• Member Committee of Medical Managers (CMM-BMA)
• Vice Chair of the Global Health Committee (GHC) Faculty of Public Health (FPH) Of the Royal College of Physicians (RCP)
• International Faculty Advisor, from 2006- 2016, to the UK Faculty of Public Health (FPH) of Royal College of Physicians (RCP).
• Chair and lead on the India Special Interest Group (SIG) in the FPH. Represented the Faculty of Public Health (FPH, UK) on the Wellcome Trust funded, UK consortium of Universities with Public Health foundations of India (PHFI)
• Honorary Senior lecturer at Imperial College London
• Adjunct Professor of Public Health at Public Health Foundations of India (PHFI) and associated Indian Institutes of Public Health (IIPH) since 2019.
• Member of European Association of Schools of Public Health Education and Research (ASPHER) responsible for establishment of Competency based training in Europe starting with Malta.
• Visiting Professor at the RDGardi, Medical College at Ujjain charitable Trust and Research Centre since 2012.
• Invited Member All India Task force set up by Ministry of Health in India, for development of Competency Based Masters in Public Health (MPH) curriculum for India where she helped develop Competency based training.
• Commissioner International Medical Commission on Bhopal (IMCB) lead for the Epidemiology 1993-date
• Expert witness, International Medical Commission on Chernobyl (IMCC) in Vienna.
• Member UK-India Parliamentary group for Health
• Project Director to establish Public Health Cadre in Odisha/ MP/ Gujarat Appointed by Department for International Development (DfID) 2014-2018
• Invited to introduce Public Health Training in WHO Geneva, WHO South East Regional Office, Finland, Malta, Oman, Kuwait in personal capacity on behalf of the FPH.
• Member of the International Science Oversight Board based in US since 2002
• International Editor / advisor Indian Journal of Public Health since 2014
Posts held in National Health Service (NHS) over 40 years
• Program Director for the National Public Health Leadership Program, (2002-2011) funded by the Department of Health Leader and a key influence in the development of the National Public Health Leadership Program for England for over 10 years that trained 700 Public Health leaders.
• Post- Graduate Dean London/ Kent Sussex and Surrey Deanery-responsible for Public Health, Clinical Genetics, Microbiology and Virology 2002-2006
• Director Postgraduate and Continuing Education for Northern and Yorkshire Deanery 1993-2002
• Director of Public Health 1986-1993 previously consultant.
Personal
• Director SDAcquilla Consultancy Limited, Training and development Company and service provider as Independent consultant in Public health,
• Managing Director Bellevue Health Care Limited (BVHC).
• President: Society of Indian Doctors (Cleveland) to promote Indian Culture and integration in Local Community and Raise funds for Charities in UK and India
• President Elect Rotary Club of Stokesley 2022/23 for Presidency 2023-24

Associate Professor Shailendra Sawleshwarkar is the Director of Academic Education and Postgraduate Coursework Programs at the Sydney Medical School, Faculty of Medicine and Health, University of Sydney. He leads the strategic direction and quality of teaching for 1200 students with a focus on executive leadership in 14 coursework master’s programs for health professionals from diverse backgrounds. With nearly 30 years of experience in curriculum development in global health partnership settings, Shailendra has been recognised for his international contribution to health professional education leadership through the award of honorary titles and awards. Shailendra has obtained several grants to support education and capacity building across South and South-East Asia and the Pacific region. HE is also a trained physician in Sexual Health and HIV and works at the intersection of clinical and public health practice which has helped provide unique perspectives and understanding across systems to shape the future health workforce.
Shailendra has prioritised research that addresses key global health challenges and championed the role of catalyst and facilitator to develop academic networks in health professional education, One Health, infectious diseases and sexual reproductive health. He is on the Research Steering group of University’s Flagship centre ‘Sydney Infectious Diseases Institute’ (Sydney ID) and leads India initiative to drive research partnerships. The educational partnership Shailendra championed between University of Sydney and the Public Health Foundation of India was featured as a part of the compendium of successful case studies commissioned by Australian Department of Foreign Affairs and Trade titled ‘Case Studies: Advocating Business Success Between Australia and India’. Coupled with his extensive experience in working across sectors and excellent diplomacy skills, Shailendra has developed productive partnerships for mutual benefit, particularly in the Asia-Pacific region.
​​

He is Professor Emeritus of the Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, USA. He holds adjunct faculty appointments at Universidad de Chile (Santiago), University of South Africa (Pretoria), Christian Medical College (Vellore, India), and Indian Institute of Technology (Delhi). He is an elected member of the International Statistical Institute.

Dr Bangdiwala focuses his expertise on the statistical aspects of longitudinal multiple-centre experimental and observational studies. As lead statistician on several NIH (USA) and CIHR (Canada) funded randomized controlled trials and longitudinal cohort studies for over 45 years, he has had the experience of collaborating with other scientists in designing, conducting, analysing and interpreting epidemiologic and clinical studies.

His main clinical areas of application are in gastrointestinal (GI) and cardiovascular (CV) diseases. He has unique experience in studying cardiometabolic risk factors as they change in children and adolescents through puberty, in studying functional GI disorders in adults, and in injury and trauma research. As Director of Statistics at PHRI, he currently oversees over 35 ongoing large randomized controlled trials of cardiovascular diseases in adults.

His statistical research has focused on methods for assessing agreement/concordance, and on understanding the sources of heterogeneity in research data. He is known as the creator of the "agreement chart" for displaying categorical discordance and concordance information. He also is well known for his international teaching of statistical concepts to non-statisticians.

​

S ("Subu") V Subramanian is a Professor of Population Health and Geography at Harvard University, and Director of a University-wide Initiative on Applied Quantitative Methods in Social Sciences. He was also the Founding Director of Graduate Studies for the interdisciplinary PhD program in Population Health Sciences. He received his under- and post-graduate training at the University of Delhi, and completed his PhD in geography from the University of Portsmouth, UK. Working in collaborations with scholars across the world, he has published over 670 articles, book chapters, and books in the field of social and contextual determinants of health, health inequalities in India, and applied multilevel statistical models. He has consistently been included in the Highly Cited Researchers (top 1% of cited publications in Web of Science) list since 2015. His current research interests are developing and applying data science approaches for precision public policy in the context of health, nutrition and development. As an educator, Subu was the first to develop a course on the concept and application of multilevel statistical methods at Harvard, which he has been successfully teaching at Harvard since 2001, as well as around the world. He has advised over 150 masters, doctoral and postdoctoral students as mentor, academic advisor and dissertation committee member. Subu is the Co-Editor-in-Chief for the international journal Social Science & Medicine (SSM), in addition to be being a Co-Senior Editor for the social epidemiology office of SSM. He is also the founding Co-Editor-in-Chief of a new journal SSM - Population Health, winner of the 2020 PROSE Award for Best New Journal in Social Sciences. He is an editorial consultant to The Lancet, and an international advisory board member for the Lancet Global Health.​